CorMedix Inc.
CRMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410098
No open-market purchases or sales by CorMedix Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $345.5M in total; no superinvestor holds it.
Superinvestors holding CRMD, Q2 2026
No superinvestor reported holding CRMD in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CRMD each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- Elliott Investment Management
Q1 2025
1 superinvestor holding at quarter end
- Reduced
- Elliott Investment Management (−14.8%)
Q4 2024
1 superinvestor holding at quarter end
- Added
- Elliott Investment Management (+85.1%)